Accelerated in vitro differentiation of blood monocytes into dendritic cells in human sepsis

被引:43
作者
Faivre, V.
Lukaszewicz, A. -C.
Alves, A.
Charron, D.
Payen, D.
Haziot, A.
机构
[1] INSERM U662, Paris, France
[2] Univ Paris, Inst Hematol, F-75010 Paris, France
[3] Univ Paris 07, Lab Anaesthesiol, EA322, Paris, France
[4] Hop Lariboisiere, Dept Anaesthesie Reanimat, SMUR, F-75475 Paris, France
[5] Hop Lariboisiere, Serv Chirurg Gen & Digest, F-75475 Paris, France
关键词
dendritic cells; differentiation; innate immunity; monocytes; sepsis;
D O I
10.1111/j.1365-2249.2006.03287.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sepsis-induced immune depression is characterized by infection susceptibility and monocyte early deactivation. Because monocytes are precursors for dendritic cells (DC), alterations in their differentiation into DC may contribute to defective immune responses in septic patients. We therefore investigated the ability of monocytes to differentiate into functional DC in vitro in patients undergoing surgery for peritonitis. Monocytes from 20 patients collected immediately after surgery (D0), at week 1 and at weeks 3-4 and from 11 control donors were differentiated into immature DC. We determined the phenotype of monocytes and derived DC, and analysed the ability of DC to respond to microbial products and to elicit T cell responses in a mixed leucocyte reaction (MLR). We show that, although monocytes from septic patients were deactivated with decreased responses to lipopolysaccharide (LPS) and peptidoglycan and low human leucocyte antigen D-related (HLA-DR) expression, they expressed the co-stimulatory molecule CD80, CD40 and CCR7. Monocytes collected from patients at D0 and week 1 differentiated faster into DC with early loss of CD14 expression. Expression of HLA-DR increased dramatically in culture to reach control levels, as did responses of DC to LPS and peptidoglycan. However, although patient and control immature DC had similar abilities to induce T cell proliferation in MLR, maturation of DC derived from patients did not increase T cell responses. These results show that circulating monocytes from septic patients express markers of activation and/or differentiation despite functional deactivation, and differentiate rapidly into phenotypically normal DC. These DC fail, however, to increase their T cell activation abilities upon maturation.
引用
收藏
页码:426 / 439
页数:14
相关论文
共 64 条
[1]   Systemic inflammatory response and progression to severe sepsis in critically ill infected patients [J].
Alberti, C ;
Brun-Buisson, C ;
Chevret, S ;
Antonelli, M ;
Goodman, SV ;
Martin, C ;
Moreno, R ;
Ochagavia, AR ;
Palazzo, M ;
Werdan, K ;
Le Gall, JR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (05) :461-468
[2]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[3]   Current epidemiology of septic shock - The CUB-Rea network [J].
Annane, D ;
Aegerter, P ;
Jars-Guincestre, MC ;
Guidet, B .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (02) :165-172
[4]  
Anton D, 1998, SCAND J IMMUNOL, V47, P116
[5]   Dendritic cells as therapeutic vaccines against cancer [J].
Banchereau, J ;
Palucka, AK .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (04) :296-306
[6]   Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood [J].
Bender, A ;
Sapp, M ;
Schuler, G ;
Steinman, RM ;
Bhardwaj, N .
JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 196 (02) :121-135
[7]   Reversal of long-term sepsis-induced immunosuppression by dendritic cells [J].
Benjamim, CF ;
Lundy, SK ;
Lukacs, NW ;
Hogaboam, CM ;
Kunkel, SL .
BLOOD, 2005, 105 (09) :3588-3595
[8]   Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories™ [J].
Berger, TG ;
Feuerstein, B ;
Strasser, E ;
Hirsch, U ;
Schreiner, D ;
Schuler, G ;
Schuler-Thurner, B .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 268 (02) :131-140
[9]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[10]   EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units [J].
Brun-Buisson, C ;
Meshaka, P ;
Pinton, P ;
Vallet, B ;
Rodie-Talbere, P ;
Zahar, JR .
INTENSIVE CARE MEDICINE, 2004, 30 (04) :580-588